Results 211 to 220 of about 27,657 (222)

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review

Clinical Therapeutics, 2000
Scott Bolesta
exaly  

Vertebral fractures in males with type 2 diabetes treated with rosiglitazone

Bone, 2009
Tatiana Mancini, Gherardo Mazziotti, Mauro Doga   +2 more
exaly  

Cardiac safety profile of rosiglitazone

International Journal of Cardiology, 2010
Edoardo Mannucci, Matteo Monami, Mauro Di Bari   +2 more
exaly  

Regulation of adipose triglyceride lipase by rosiglitazone

Diabetes, Obesity and Metabolism, 2009
Kazunori Koba
exaly  

Rosiglitazone inhibits Kv4.3 potassium channels by open‐channel block and acceleration of closed‐state inactivation

British Journal of Pharmacology, 2011
Bok Hee Choi
exaly  

Rosiglitazone

Reactions Weekly, 2002
  +4 more sources

Rosiglitazone Attenuates Liver Inflammation in a Rat Model of Nonalcoholic Steatohepatitis

Digestive Diseases and Sciences, 2007
Veysel Tahan, Fatih Eren, Erol Avsar
exaly  

A case of rosiglitazone exposure in the second trimester of pregnancy

Reproductive Toxicology, 2005
Mine Kadioglu, Murat Kesim, Mesut A Unsal   +2 more
exaly  

Rosiglitazone saga. Demonisation of rosiglitazone.

BMJ (Clinical research ed.), 2011
openaire   +1 more source

An improved LC–ESI–MS–MS method for simultaneous quantitation of rosiglitazone and N-desmethyl rosiglitazone in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2008
Sudhakar M Pai
exaly